SRX Health Solutions Q3 sales rise on Halo strength

SRx Global

13/08/2026 21:18

Overview
US AI-enabled investment platform's fiscal Q3 sales rose 27% yr/yr
Adjusted EBITDA loss for fiscal Q3 improved 35% yr/yr to $1.6 mln
Company approved 10 mln share repurchase and declared one-time $0.05 per share dividend

Outlook
Company to focus on phased deployment of EMJX digital-asset treasury strategy and commercialization
SRX to allocate capital to support Halo revenue growth, margin expansion and business optimization
Company plans selective investments in technology, fintech, biotech, and critical infrastructure based on risk-adjusted returns

Result Drivers
HALO OPERATIONS - Co said improved fill rates and record Prime Day performance at Halo contributed to sales growth
EMJX ACQUISITION - Co completed acquisition of EMJX and began integrating its AI-driven investment models
DIGITAL ASSET LOSSES - Co recognized $1.4 mln loss from changes in fair value of digital assets, partly offset by gains in equity securities and derivative liabilities

Company press release: ID:nGNX5BBFXp

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
 
$3.39 mln
 
Q3 Net Loss
 
$4.14 mln
 
Q3 Adjusted EBITDA
 
-$1.60 mln
 

Reuters Recommended Reads
Aug 11 - Trading platform eToro beats profit estimates, targets US growth with TradeZero buy
Aug 12 - US Realbotix Q3 revenue falls on Intima repositioning and crypto exit
Aug 12 - DeFi Development Q2 revenue rises on digital asset treasury growth

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)